Antibiotic LL-E19085 Alpha

This disclosure describes a novel antibacterial agent designated LL-E10985a, its production by aerobic fermentation of a new subspecies of Micromonospora citrea NRRL 18351 mutants thereof, and the isolation and purification thereof.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	GOODMAN, JOSEPH JACOB, CARTER, GUY THOMAS, LABEDA, DAVID PAUL
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF COMPOUNDS OF UNKNOWN CONSTITUTION CULTURE MEDIA ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROCESSES USING MICROORGANISMS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	This disclosure describes a novel antibacterial agent designated LL-E10985a, its production by aerobic fermentation of a new subspecies of Micromonospora citrea NRRL 18351 mutants thereof, and the isolation and purification thereof.